FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q96307579> ?p ?o ?g. }

• Q96307579 description "2020 nî lūn-bûn" @default.
• Q96307579 description "2020 թվականի հունիսի 10-ին հրատարակված գիտական հոդված" @default.
• Q96307579 description "2020年の論文" @default.
• Q96307579 description "2020年学术文章" @default.
• Q96307579 description "2020年学术文章" @default.
• Q96307579 description "2020年学术文章" @default.
• Q96307579 description "2020年学术文章" @default.
• Q96307579 description "2020年学术文章" @default.
• Q96307579 description "2020年学术文章" @default.
• Q96307579 description "2020年學術文章" @default.
• Q96307579 description "2020年學術文章" @default.
• Q96307579 description "2020年學術文章" @default.
• Q96307579 description "2020年學術文章" @default.
• Q96307579 description "2020年學術文章" @default.
• Q96307579 description "2020년 논문" @default.
• Q96307579 description "article científic" @default.
• Q96307579 description "article scientific" @default.
• Q96307579 description "article scientifique" @default.
• Q96307579 description "articol științific" @default.
• Q96307579 description "articolo scientifico" @default.
• Q96307579 description "artigo científico" @default.
• Q96307579 description "artigo científico" @default.
• Q96307579 description "artigo científico" @default.
• Q96307579 description "artikel ilmiah" @default.
• Q96307579 description "artikull shkencor" @default.
• Q96307579 description "artikulong pang-agham" @default.
• Q96307579 description "artykuł naukowy" @default.
• Q96307579 description "artículo científico publicado en 2020" @default.
• Q96307579 description "artículu científicu" @default.
• Q96307579 description "bilimsel makale" @default.
• Q96307579 description "bài báo khoa học" @default.
• Q96307579 description "naučni članak" @default.
• Q96307579 description "scienca artikolo" @default.
• Q96307579 description "scientific article published on 10 June 2020" @default.
• Q96307579 description "scientific article published on 10 June 2020" @default.
• Q96307579 description "scientific article published on 10 June 2020" @default.
• Q96307579 description "teaduslik artikkel" @default.
• Q96307579 description "tieteellinen artikkeli" @default.
• Q96307579 description "tudományos cikk" @default.
• Q96307579 description "vedecký článok" @default.
• Q96307579 description "vetenskaplig artikel" @default.
• Q96307579 description "videnskabelig artikel udgivet 10. juni 2020" @default.
• Q96307579 description "vitenskapelig artikkel" @default.
• Q96307579 description "vitskapeleg artikkel" @default.
• Q96307579 description "vědecký článek" @default.
• Q96307579 description "wetenschappelijk artikel" @default.
• Q96307579 description "wissenschaftlicher Artikel" @default.
• Q96307579 description "επιστημονικό άρθρο" @default.
• Q96307579 description "мақолаи илмӣ" @default.
• Q96307579 description "наукова стаття, опублікована в червні 2020" @default.
• Q96307579 description "научна статия" @default.
• Q96307579 description "научная статья" @default.
• Q96307579 description "научни чланак" @default.
• Q96307579 description "научни чланак" @default.
• Q96307579 description "מאמר מדעי" @default.
• Q96307579 description "مقالة علمية نشرت في 10 يونيو 2020" @default.
• Q96307579 description "১০ জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q96307579 description "บทความทางวิทยาศาสตร์" @default.
• Q96307579 description "სამეცნიერო სტატია" @default.
• Q96307579 name "Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)" @default.
• Q96307579 name "Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)" @default.
• Q96307579 type Item @default.
• Q96307579 label "Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)" @default.
• Q96307579 label "Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)" @default.
• Q96307579 prefLabel "Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)" @default.
• Q96307579 prefLabel "Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)" @default.
• Q96307579 P1433 Q96307579-C0351CA4-EB1C-4DAA-9758-408B627D64F2 @default.
• Q96307579 P1476 Q96307579-CA5FD2BD-75D3-41BD-BC66-04E33DE32208 @default.
• Q96307579 P2093 Q96307579-0A961850-0DFC-410E-A842-430E79608751 @default.
• Q96307579 P2093 Q96307579-27351F4D-64C4-4B8E-B7B8-2F07DFFE53B3 @default.
• Q96307579 P2093 Q96307579-33854553-3D82-438D-B761-49F89F6C74A8 @default.
• Q96307579 P2093 Q96307579-34C8FD9E-40DA-4F23-A6F2-D48F409EA20E @default.
• Q96307579 P2093 Q96307579-3B23A3E4-192A-436B-A6B2-FD79FCA8D7C5 @default.
• Q96307579 P2093 Q96307579-4BFA3280-3513-44C4-B832-932F6BF51170 @default.
• Q96307579 P2093 Q96307579-4DAA2203-F4B0-44E6-814F-28BEDA65FB60 @default.
• Q96307579 P2093 Q96307579-4E982699-0C91-4DEA-B604-474F0869C055 @default.
• Q96307579 P2093 Q96307579-6FADB85D-6460-4CE3-9B9F-9671C767D005 @default.
• Q96307579 P2093 Q96307579-880F1E89-EC12-47B6-9F60-C80E53E4EC4E @default.
• Q96307579 P2093 Q96307579-A20D5370-AB57-4D49-9B33-F07C20D9FC22 @default.
• Q96307579 P2093 Q96307579-AEA26103-F258-4E33-BB95-499E58BD2F81 @default.
• Q96307579 P2093 Q96307579-BA8F1AC6-D7A1-47BF-BC2E-ECD3DAF320F3 @default.
• Q96307579 P2093 Q96307579-BF29A5AA-FD3C-48EC-AAC8-A60D7375A76A @default.
• Q96307579 P2093 Q96307579-CCD11210-D633-4A6D-966C-9EFC35DD672A @default.
• Q96307579 P2093 Q96307579-DA96FC10-FFF6-4A7F-846B-343DA644B702 @default.
• Q96307579 P2093 Q96307579-DB0BCEB3-A4E1-47C0-BDB5-AD8AC2630196 @default.
• Q96307579 P31 Q96307579-11A99641-A087-4134-95C3-3CF5933E1F91 @default.
• Q96307579 P356 Q96307579-6B430BED-1A97-45BE-89BA-8013F442795A @default.
• Q96307579 P50 Q96307579-CEC747CB-AF46-4CF7-AC7D-9D6A42157B6F @default.
• Q96307579 P577 Q96307579-F14AEDBF-5A67-4F66-9370-430C711176E2 @default.
• Q96307579 P698 Q96307579-6D19DE9F-53EE-47E5-AA2C-BF98FA5C974B @default.
• Q96307579 P921 Q96307579-B3E9C91E-F1F6-4A59-94D7-02430A5F7AE9 @default.
• Q96307579 P921 Q96307579-E5915655-A834-4C88-8BED-29149E8CAF14 @default.
• Q96307579 P356 S11739-020-02386-0 @default.
• Q96307579 P698 32524338 @default.
• Q96307579 P1433 Q26842320 @default.
• Q96307579 P1476 "Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)" @default.
• Q96307579 P2093 "Andreina Manfredi" @default.
• Q96307579 P2093 "Anna Linda Zignego" @default.
• Q96307579 P2093 "Antonio Tavoni" @default.
• Q96307579 P2093 "Caterina Vacchi" @default.

• next